In the present study, KCa3.1 KO had no effect on the sensitivity of MMTV-PyMT breast cancer cells to docetaxel, doxorubicin, 5-fluorouracil, or cyclophosphamide. The gene discussed is KCNN4; the disease is breast carcinoma.